Transarterial Chemoembolization with Epirubicin-eluting Beads versus Transarterial Embolization before Liver Transplantation for Hepatocellular Carcinoma

Journal of Vascular and Interventional Radiology

Volumn 21, Issue 3, 2010, Pages 327-332

  Nicolini, Antonio ^a   Martinetti, Laura ^a   Crespi, Silvia ^a   Maggioni, Marco ^b   Sangiovanni, Angelo ^a  

^a Istitudo di Ricovero e Cura a Carattere Scientifico Multimedia Scientific and Technology Pole   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; EPIRUBICIN; STEROID;

ABDOMINAL PAIN; ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COUGHING; DEVASCULARIZATION; DISEASE COURSE; FEMALE; FEVER; FOLLOW UP; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; PRURITUS; TUMOR NECROSIS;

ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; DELAYED-ACTION PREPARATIONS; EMBOLIZATION, THERAPEUTIC; EPIRUBICIN; FEMALE; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PREMEDICATION; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 76649124246     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2009.10.038     Document Type: Article

References (28)

1. Bismuth H., Majno P.E., and Adam R. Liver transplantation for hepatocellular carcinoma. Semin Liver Dis 19 (1999) 311-322
2. Dharancy S., Boitard J., Decaens T., et al. Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Liver Transpl 13 (2007) 665-671
3. Majno P., Giostra E., Morel P., Hadengue A., and Mentha G. Management of hepatocellular carcinoma in the waiting list before liver transplantation. J Hepatol 42 Suppl (2005) S134-S143
4. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of a small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med 334 (1996) 693-700
5. Group d'Etude et de Traitment du carcinome Hepetocellulaire. A comparison of Lipiodol chemoembolization and consrvative treatment for unresectable hepatocellular carcinoma. N Engl J Med 332 (1995) 1256-1261
6. Llovet J.M., Real M.I., Montaña X., et al., Barcelona Liver Cancer Group. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359 (2002) 1734-1739
7. Llovet J.M., and Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37 (2003) 429-442
8. Ravaioli M., Grazi G.L., Ercolani G., et al. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation 78 (2004) 1780-1786
9. Lewis A.L., Gonzalez M.V., Lloyd A.W., et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17 (2006) 335-342
10. Hong K., Khwaja A., Liapi E., Torbenson M.S., Georgiades C.S., and Geschwind J.F. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12 (2006) 2563-2567
11. Varela M., Real M.I., Burrel M., et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46 (2007) 474-481
12. Malagari K., Alexopoulou E., Chatzimichail K., et al. Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. Abdom Imaging 33 (2008) 512-519
13. Nicolini A., Fasani P., Manini M.A., et al. Transarterial embolization with microspheres in the treatment of monofocal HCC. Dig Liver Dis 41 (2009) 143-149
14. Pugh R.N., Murray-Lyon I.M., Dawson J.L., Pietroni M.C., and Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60 (1973) 646-649
15. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
16. Llovet J.M., Brù C., and Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 19 (1999) 329-338
17. Sacks D., McClenny T.E., Cardella J.F., and Lewis C.A. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14 Suppl (2003) S199-S202
18. World Health Organization. Classification of tumors: pathology and genetics of tumors of the digestive system (2000), IARC Press, Lyon, France 157-172
19. Sobin L.H., and Wittekind C. International Union Against Cancer (UICC) TNM classification of malignant tumors. 6th ed. (2002), Wiley-Liss, New York 99-103
20. Edmonson H.A., and Steiner P.E. Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies. Cancer 7 (1954) 462-503
21. Belghiti J., Carr B.I., Greig P.D., Lencioni R., and Poon R.T. Treatment before liver transplantation for HCC. Ann Surg Oncol 15 (2008) 993-1000
22. Adam R., Azoulay D., Castaing D., et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy?. Ann Surg 238 (2003) 508-519
23. Moreno Planas J.M., López Monclús J., Gómez Cruz A., et al. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation. Transplant Proc 37 (2005) 1484-1485
24. Sotiropoulos G.C., Malagó M., Molmenti E., et al. Efficacy of transarterial chemoembolization prior to liver transplantation for hepatocellular carcinoma as found in pathology. Hepatogastroenterology 52 (2005) 329-332
25. Poon R.T., Tso W.K., Pang R.W., et al. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol 5 (2007) 1100-1108
26. Lewis A.L., Taylor R.R., Hall B., Gonzalez M.V., Willis S.L., and Stratford P.W. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 17 (2006) 1335-1343
27. Barbara L., Benzi G., Gaioni S., et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatolgy 16 (1992) 132-137
28. Okazaki N., Yoshino M., Yoshida T., et al. Evaluation of the prognosis for small hepatocellular carcinoma based on tumor volume doubling time: a preliminary report. Cancer 63 (1989) 2207-2210